{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:25:55Z","timestamp":1791257155136,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jaci.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,3,29]],"date-time":"2013-03-29T20:00:59Z","timestamp":1364587259000},"page":"1408-1416.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["A novel splice variant of Fc\u03b3RIIa: A\u00a0risk factor for anaphylaxis in patients with hypogammaglobulinemia"],"prefix":"10.1016","volume":"131","author":[{"given":"Joris","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"van Mirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Deuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos W.M.","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulgabar","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo K.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Roos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco W.","family":"Kuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.02.009_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.02.009_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib3","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.02.009_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1034\/j.1399-0039.2003.00037.x","article-title":"FcgammaR polymorphisms: implications for function, disease susceptibility and immunotherapy","volume":"61","author":"van Sorge","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaci.2013.02.009_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.172.1.19","article-title":"Molecular basis for a polymorphism of human Fc gamma receptor II (CD32)","volume":"172","author":"Warmerdam","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.02.009_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1084\/jem.170.4.1369","article-title":"Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes","volume":"170","author":"Brooks","year":"1989","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.02.009_bib7","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood.V85.8.2202.bloodjournal8582202","article-title":"Identification of signaling motifs within human Fc gamma RIIa and Fc gamma RIIb isoforms","volume":"85","author":"Van den Herik-Oudijk","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.02.009_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.152.2.574","article-title":"Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes","volume":"152","author":"Van Den Herik-Oudijk","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib9","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1016\/S0021-9258(18)53181-1","article-title":"The human low affinity immunoglobulin G Fc receptor IIC gene is a result of an unequal crossover event","volume":"268","author":"Warmerdam","year":"1993","journal-title":"J Biol Chem"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2013.02.009_bib10","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1038\/sj.gene.6363879","article-title":"Genomic organization of classical human low-affinity Fcgamma receptor genes","volume":"3","author":"Su","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2013.02.009_bib11","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.4049\/jimmunol.162.7.4311","article-title":"The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: a transgenic mouse model","volume":"162","author":"McKenzie","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib12","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood-2011-07-367334","article-title":"Human FcgammaRIIA induces anaphylactic and allergic reactions","volume":"119","author":"Jonsson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.02.009_bib13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1126\/science.291.5503.484","article-title":"Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor","volume":"291","author":"Samuelsson","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.02.009_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.166.1.531","article-title":"Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines","volume":"166","author":"Pricop","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood-2005-12-4997","article-title":"Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory Fc\u03b3RII (CD32), is stable over time and unaffected by cytokines","volume":"108","author":"Van Mirre","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.02.009_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.02.009_bib17","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaci.2013.02.009_bib18","first-page":"213","article-title":"Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy","volume":"61","author":"Eijkhout","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaci.2013.02.009_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2249.2007.03483.x","article-title":"Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment","volume":"151","author":"Ahrens","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2249.1998.00571.x","article-title":"Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy","volume":"112","author":"Sundin","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib21","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.141.5.1602","article-title":"Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies","volume":"141","author":"Hack","year":"1988","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.1998.00697.x","article-title":"Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in\u00a0vitro","volume":"114","author":"Teeling","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0022-1759(93)90240-8","article-title":"Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway","volume":"163","author":"Wolbink","year":"1993","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2013.02.009_bib24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jim.2004.12.018","article-title":"Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation","volume":"298","author":"Wouters","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2013.02.009_bib25","first-page":"54","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency","volume":"2","author":"Al-Herz","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/07853899808999383","article-title":"Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology","volume":"30","author":"George","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.jaci.2013.02.009_bib27","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/adc.67.8.1056","article-title":"Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group","volume":"67","author":"Eden","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2013.02.009_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0167-4889(97)00034-7","article-title":"Influence of tyrosine phosphorylation on protein interaction with FcgammaRIIa","volume":"1357","author":"Ibarrola","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaci.2013.02.009_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1423-0410.2001.00047.x","article-title":"Rapid detection of antibodies to immunoglobulin A\u00a0molecules by using the particle gel immunoassay","volume":"81","author":"Salama","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.jaci.2013.02.009_bib30","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4049\/jimmunol.1003945","article-title":"Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles","volume":"188","author":"van der Heijden","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib31","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2013.02.009_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpedi.154.7.694","article-title":"Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease","volume":"154","author":"Han","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaci.2013.02.009_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/adc.2007.126144","article-title":"Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease","volume":"93","author":"Furukawa","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2013.02.009_bib34","doi-asserted-by":"crossref","first-page":"E640","DOI":"10.1002\/humu.20997","article-title":"Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B","volume":"30","author":"Breunis","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaci.2013.02.009_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2007-03-079913","article-title":"Copy number variation of the activating FCGR2C gene predisposes to idiopathic thrombocytopenic purpura","volume":"111","author":"Breunis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.02.009_bib36","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1093\/nar\/gkg616","article-title":"ESEfinder: a web resource to identify exonic splicing enhancers","volume":"31","author":"Cartegni","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2013.02.009_bib37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4049\/jimmunol.173.1.332","article-title":"Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb","volume":"173","author":"van Mirre","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(68)90527-8","article-title":"Anaphylactoid transfusion reactions associated with anti-IgA","volume":"2","author":"Vyas","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2013.02.009_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00062752-200311000-00004","article-title":"Anaphylactic transfusion reactions","volume":"10","author":"Gilstad","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jaci.2013.02.009_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1537-2995.2004.03316.x","article-title":"A new strategy for the prevention of IgA anaphylactic transfusion reactions","volume":"44","author":"Salama","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2013.02.009_bib41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","article-title":"The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature","volume":"129","author":"Rachid","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006650812886","article-title":"IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy","volume":"20","author":"de Albuquerque","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2013.02.009_bib43","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3812::AID-IMMU3812>3.0.CO;2-N","article-title":"The CD40 TRAF family member interacting motif carries the information to rescue WEHI 231 cells from anti-IGM-induced growth arrest","volume":"28","author":"Hornung","year":"1998","journal-title":"Eur J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913003151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913003151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:40:25Z","timestamp":1758789625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913003151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0091674913003151"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.02.009","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel splice variant of Fc\u03b3RIIa: A\u00a0risk factor for anaphylaxis in patients with hypogammaglobulinemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}